BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1 AND Prognosis
11 results:

  • 1. LncRNA GAS5 Regulates Gemcitabine Resistance in pancreatic Carcinoma by Targeting miRNA-21.
    Huang K; Yang G
    Ann Clin Lab Sci; 2023 Mar; 53(2):222-229. PubMed ID: 37094852
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. FZD7 accelerates hepatic metastases in pancreatic cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling.
    Zhang Z; Xu Y
    Mol Med; 2022 Jul; 28(1):82. PubMed ID: 35854234
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. cancer Stem Cell Markers in Relation to Patient Survival Outcomes: Lessons for Integrative Diagnostics and Next-Generation Anticancer Drug Development.
    Dzobo K; Ganz C; Thomford NE; Senthebane DA
    OMICS; 2021 Feb; 25(2):81-92. PubMed ID: 33170084
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Variants in oxidative stress-related genes affect the chemosensitivity through Nrf2-mediated signaling pathway in biliary tract cancer.
    Zhan M; Wang H; Xu SW; Yang LH; Chen W; Zhao SX; Shen H; Liu Q; Yang RM; Wang J
    EBioMedicine; 2019 Oct; 48():143-160. PubMed ID: 31590928
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. pancreatic cancer stem cells: features and detection methods.
    Ishiwata T; Matsuda Y; Yoshimura H; Sasaki N; Ishiwata S; Ishikawa N; Takubo K; Arai T; Aida J
    Pathol Oncol Res; 2018 Oct; 24(4):797-805. PubMed ID: 29948612
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Elevation of β-galactoside α2,6-sialyltransferase 1 in a fructoseresponsive manner promotes pancreatic cancer metastasis.
    Hsieh CC; Shyr YM; Liao WY; Chen TH; Wang SE; Lu PC; Lin PY; Chen YB; Mao WY; Han HY; Hsiao M; Yang WB; Li WS; Sher YP; Shen CN
    Oncotarget; 2017 Jan; 8(5):7691-7709. PubMed ID: 28032597
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PIM-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value.
    Xu J; Xiong G; Cao Z; Huang H; Wang T; You L; Zhou L; Zheng L; Hu Y; Zhang T; Zhao Y
    J Exp Clin Cancer Res; 2016 Sep; 35(1):133. PubMed ID: 27596051
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Minnelide effectively eliminates CD133(+) side population in pancreatic cancer.
    Nomura A; McGinn O; Dudeja V; Sangwan V; Saluja AK; Banerjee S
    Mol Cancer; 2015 Nov; 14():200. PubMed ID: 26597727
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The clinical significance of FRAT1 and abcg2 expression in pancreatic ductal adenocarcinoma.
    Yuan Y; Yang Z; Miao X; Li D; Liu Z; Zou Q
    Tumour Biol; 2015 Dec; 36(12):9961-8. PubMed ID: 26178481
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients.
    Lee SH; Kim H; Hwang JH; Lee HS; Cho JY; Yoon YS; Han HS
    Pathol Int; 2012 Mar; 62(3):167-75. PubMed ID: 22360504
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. cancer stem-like cells enriched in Panc-1 spheres possess increased migration ability and resistance to gemcitabine.
    Yin T; Wei H; Gou S; Shi P; Yang Z; Zhao G; Wang C
    Int J Mol Sci; 2011; 12(3):1595-604. PubMed ID: 21673909
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.